Plandai Biotechnology (Plandai Biotechnology) Debt-to-Equity : -0.11 (As of Jun. 2023)

View and export this data going back to . Start your Free Trial

What is Plandai Biotechnology Debt-to-Equity?

Plandai Biotechnology's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was $0.05 Mil. Plandai Biotechnology's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was $0.00 Mil. Plandai Biotechnology's Total Stockholders Equity for the quarter that ended in Jun. 2023 was $-0.44 Mil. Plandai Biotechnology's debt to equity for the quarter that ended in Jun. 2023 was -0.11.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Plandai Biotechnology's Debt-to-Equity or its related term are showing as below:

PLPL' s Debt-to-Equity Range Over the Past 10 Years
Min: -4.24 Med: -1.46 Max: -0.08
Current: -0.11

During the past 13 years, the highest Debt-to-Equity Ratio of Plandai Biotechnology was -0.08. The lowest was -4.24. And the median was -1.46.

PLPL's Debt-to-Equity is not ranked
in the Diversified Financial Services industry.
Industry Median: 0.13 vs PLPL: -0.11

Plandai Biotechnology Debt-to-Equity Historical Data

The historical data trend for Plandai Biotechnology's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Plandai Biotechnology Debt-to-Equity Chart

Plandai Biotechnology Annual Data

Trend

Mar09

Mar10

Mar11

Jun12

Jun13

Jun14

Jun15

Jun16

Jun22

Jun23

Debt-to-Equity

Get a 7-Day Free Trial

-4.24

-2.22

-1.46

-0.08

-0.11

Plandai Biotechnology Semi-Annual Data
	Mar03	Mar04	Mar05	Mar06	Mar07	Mar08	Mar09	Mar10	Mar11	Jun12	Jun13	Jun14	Jun15	Jun16	Jun22	Jun23
Debt-to-Equity	Get a 7-Day Free Trial											-4.24	-2.22	-1.46	-0.08	-0.11

Competitive Comparison of Plandai Biotechnology's Debt-to-Equity

For the Shell Companies subindustry, Plandai Biotechnology's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Plandai Biotechnology's Debt-to-Equity Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Plandai Biotechnology's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Plandai Biotechnology's Debt-to-Equity falls into.

Plandai Biotechnology Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Plandai Biotechnology's Debt to Equity Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.05	+	0)	/	-0.443
	=	-0.11

Plandai Biotechnology's Debt to Equity Ratio for the quarter that ended in Jun. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.05	+	0)	/	-0.443
	=	-0.11

Plandai Biotechnology (OTCPK:PLPL) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Plandai Biotechnology Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Plandai Biotechnology's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Plandai Biotechnology (Plandai Biotechnology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Plandai Biotechnology Inc (OTCPK:PLPL) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

4811 49th Street, San Diego, CA, USA, 92115

Website

http://www.plandaibiotech.com

Plandai Biotechnology Inc. manufactures highly bioavailable extracts from live plant materials.

Executives

Callum Baylis-duffield	director	FLAT 37 ISLAND HOUSE THREE MILL LANE, LONDON ENGLAND X0 E33AF
Timothy Matula	other: Former Director	175 JACKSON AVE N, SUITE 102, MINNEAPOLIS MN 55343
Brian Johnson	director	P.O. BOX 1594, FERNDALE WA 98248-1594
Roger Duffield	director, officer: President, Secretary and CFO	2226 EASTLAKE AVENUE EAST #156, SEATTLE WA 98102
Daron Baylis Duffield	director	2226 EASTLAKE AVENUE EAST #156, SEATTLE WA 98102
David Rzepnicki	director	21 HORIZON DRIVE, SARATOGA SPRINGS NY 12866